Also known as Acetyl Octapeptide-3 · Acetyl Octapeptide-1 · Ac-EEMQRRAD-NH2
An elongated, higher-potency relative of Argireline — an eight-residue SNAP-25 mimic used as a topical, needle-free anti-wrinkle peptide.
Research refreshed
SNAP-8 (acetyl octapeptide-3) is a topical anti-aging peptide closely related to Argireline: it extends the same acetylated SNAP-25-mimicking sequence from six residues to eight, and is marketed as a more potent version of the same "topical Botox" concept. Like Argireline, it is proposed to interfere with the SNARE complex that triggers muscle contraction, softening expression lines when applied to the skin.
SNAP-8 is Argireline’s longer sibling. Where Argireline is a six-residue fragment mimicking the tip of SNAP-25, SNAP-8 extends the same idea to eight residues (acetyl octapeptide-3), a change its developers positioned as improving the peptide’s ability to compete in the SNARE complex and therefore its wrinkle-softening effect. The mechanism is identical in spirit: interfere with the docking machinery that lets a nerve tell a facial muscle to contract.
It is used the same way as Argireline — a cosmetic-formulation ingredient in topical serums and creams, not an injectable — and the same caveat applies: the effects are modest and surface-level next to injected botulinum toxin, and the marketing tends to outrun the controlled evidence. It is catalogued here as a well-defined companion to Argireline on the cosmetic-peptide shelf. It is a cosmetic ingredient, not an FDA-approved drug.
An elongated SNAP-25 N-terminal mimic that competes in SNARE-complex assembly, reducing neurotransmitter release at the neuromuscular junction and the muscle contractions that create expression wrinkles.
Behind every vial of SNAP-8 is the same exacting pipeline every research peptide runs — but the chemistry plays out differently for this molecule. Here is how SNAP-8, specifically, is brought into being.
On paper, SNAP-8 is C41H70N16O16S — about 1,075.2 daltons of precisely arranged atoms. Before a single bond is made, the target sequence, salt form, and purity threshold are written down as the contract the finished material must meet.
SNAP-8 is built one protected residue at a time by solid-phase synthesis, each cycle a deprotection, a coupling, and a wash. Its C-terminus is amidated rather than left as a free acid — a defined modification the synthesis has to deliver, not an afterthought.
The crude mixture — SNAP-8 plus its deletions and side products — is then separated on preparative HPLC, and where the cut is taken decides the difference between a genuinely pure peptide and a barely-passable one.
A real batch of SNAP-8 proves itself: identity confirmed by mass spectrometry against its ~1,075.2 Da, purity read directly off an analytical HPLC trace, water and counterion content measured. That batch-specific certificate of analysis is the only honest way to know what is actually in a vial of SNAP-8 — and a short, cold, accountable chain of custody is how that purity survives the trip to your bench.
SNAP-8 (acetyl octapeptide-3) is the eight-residue analog of Argireline, N-acetylated and C-terminally amidated, made by solid-phase synthesis. The two extra residues add little difficulty; as with Argireline the terminal modifications and counterion control are the quality-defining features.
Don't judge a vial by its cake. A fluffy, good-looking lyophilized powder reflects bulking agents and freeze-drying parameters — not purity. Insist on a batch-specific certificate of analysis.
SNAP-8 (acetyl octapeptide-3) is a topical anti-aging peptide, an eight-residue relative of Argireline that mimics SNAP-25 to soften expression wrinkles.
SNAP-8 extends Argireline’s six-residue sequence to eight residues and is marketed as more potent, but the mechanism and topical use are the same and comparative evidence is limited.
No — like Argireline it is a topical cosmetic ingredient. Its effects are modest and superficial compared with injected botulinum toxin.
It is a cosmetic ingredient, not an FDA-approved drug. This page is a research and educational reference.
Endogenous copper-binding tripeptide widely studied in skin and hair biology.
ViewCopper-binding tripeptide (Ala-His-Lys) studied for hair-follicle stimulation and dermal repair.
ViewPalmitoylated matrikine peptide that signals fibroblasts to synthesize collagen — contains no copper.
ViewDosing protocols, mechanism, comparisons, and the latest trials — citation-backed answers grounded in PubMed, PubChem, and ClinicalTrials.gov.